[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Citeline Launches AI Importer to Optimize Global Clinical Trial Disclosure Workflows

Home | Citeline

Citeline announces the launch of the AI Importer tool within its industry-leading TrialScope Disclose platform for clinical trial disclosure management. This AI-driven enhancement automates the extraction of key data elements from clinical trial protocols.

New artificial intelligence capability in TrialScope Disclose streamlines protocol processing, reduces manual effort, and empowers sponsors to bring work in-house

Citeline, a global leader in clinical trial intelligence and technology solutions, announces the launch of the AI Importer tool within its industry-leading TrialScope Disclose platform. This AI-driven enhancement automates the extraction of key data elements from clinical trial protocols, accelerating the initiation of disclosure workflows and minimizing manual input.

Trusted by the world’s largest biopharma companies, TrialScope Disclose manages disclosure for nearly 40 percent of industry clinical trials. The AI Importer feature marks a pivotal advancement in Citeline’s broader investment in AI-powered workflow automation, helping life sciences organizations navigate increasingly complex clinical development with greater speed and accuracy. Such automation benefits Citeline experts as well, who can shift their focus from handling administrative tasks to addressing more global client and industry priorities.

Related Posts
1 of 42,205

Also Read: AiThority Interview with Tim Morrs, CEO at SpeakUp

“Our customers are under growing pressure to disclose more data, across more regions, faster than ever before,” Thomas Wicks, Head of Transparency at Citeline. ”AI Importer represents a major leap forward, using artificial intelligence to extract structured data directly from clinical protocols and auto-populate disclosure forms. What used to take hours and weeks now takes minutes.”

The importer automatically leverages AI to identify and map critical protocol information — such as study design, arms, endpoints, and timelines — into a study sponsor’s disclosure workflow, where it is accessible for user review. AI Importer promotes faster, more consistent form completion while reducing the risk of error associated with manual data entry.

This launch is a significant development Citeline’s ongoing strategy to infuse AI across its product suite, boosting automation, improving data integrity, and driving smarter, more scalable operations in clinical planning and development.

Also Read: Cognitive Product Design: Empowering Non-Technical Users Through Natural Language Interaction With AI-Native PLM

[To share your insights with us as part of editorial or sponsored content, please write to psen@itechseries.com]

Comments are closed.